Literature DB >> 35014118

CORRECTION.

.   

Abstract

Entities:  

Year:  2022        PMID: 35014118      PMCID: PMC8748247          DOI: 10.1111/cas.15219

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


× No keyword cloud information.
In an article titled “VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers” by Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani, Go Makimoto, Kiichiro Ninomiya, Kazuya Nishii, Hisao Higo, Chihiro Ando, Sachi Okawa, Takamasa Nakasuka, Hirohisa Kano, Naofumi Hara, Atsuko Hirabae, Yuka Kato, Takashi Ninomiya, Toshio Kubo, Kammei Rai, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, and Katsuyuki Kiura, the authors would like to correct the first image from the right at the top row of Figure 6B. The correct figure 6B is shown below. The authors apologize for the error.
  1 in total

1.  VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.

Authors:  Hiromi Watanabe; Eiki Ichihara; Hiroe Kayatani; Go Makimoto; Kiichiro Ninomiya; Kazuya Nishii; Hisao Higo; Chihiro Ando; Sachi Okawa; Takamasa Nakasuka; Hirohisa Kano; Naofumi Hara; Atsuko Hirabae; Yuka Kato; Takashi Ninomiya; Toshio Kubo; Kammei Rai; Kadoaki Ohashi; Katsuyuki Hotta; Masahiro Tabata; Yoshinobu Maeda; Katsuyuki Kiura
Journal:  Cancer Sci       Date:  2021-03-18       Impact factor: 6.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.